2m 2m 2m 2m 2m 2m 2m
ALECTOR (ALEC)
NASDAQ
$1.80+$0.02 (+1.13%)
Price as of Jun 03, 2026 6:44 PM EDT- $239.8MMarket Cap
- 14.52%1-Year Change
- BiotechnologyIndustry
ALECTOR (ALEC)
$1.80+$0.02 (+1.13%)
Annual
Quarterly
12/31/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 21.0M -78.32% | 97.1M -27.36% | 133.6M -35.48% | 207.1M +881.54% | |
Cost of Revenue | N/A N/A | 0 N/A | N/A N/A | N/A N/A | |
Gross Profit | 21.0M -78.32% | 97.1M -27.36% | 133.6M -35.48% | 207.1M +881.54% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -123.1M -35.94% | -192.1M -8.70% | -210.4M +11.09% | -189.4M +20.74% | |
Depreciation and Amortization Expense | 5.7M -0.12% | 5.7M +0.19% | 5.7M -9.72% | 6.3M +7.82% | |
Total Operating Expenses | 177.1M -28.84% | 248.8M -8.34% | 271.5M +11.05% | 244.4M +13.03% | |
Operating Profit | -156.0M +2.81% | -151.7M +10.09% | -137.8M +268.93% | -37.4M -80.86% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 13.2M -50.13% | 26.6M +241.49% | 7.8M +654.41% | 1.0M -79.15% | |
Income before Taxes | -142.8M +14.05% | -125.2M -3.75% | -130.1M +248.12% | -37.4M -80.86% | |
Income Taxes | 168,000 -96.78% | 5.2M +60.17% | 3.3M N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -142.9M +9.62% | -130.4M -2.19% | -133.3M +266.95% | -36.3M -80.90% | |
Net Income from Continuing Operations Applicable to Common | -142.9M +9.62% | -130.4M -2.19% | -133.3M +266.95% | -36.3M -80.90% | |
Basic EPS and Net Income | -1.39 -10.90% | -1.56 -3.70% | -1.62 +260.00% | -0.45 -81.63% | |
Diluted EPS and Net Income | -1.39 -10.90% | -1.56 -3.70% | -1.62 +260.00% | -0.45 -81.63% | |
Basic Weighted Average Shares | 103.0M +23.01% | 83.7M +1.54% | 82.5M +2.55% | 80.4M +3.42% | |
Diluted Weighted Average Shares | 103.0M +23.01% | 83.7M +1.54% | 82.5M +2.55% | 80.4M +3.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 65.8M -11.74% | 74.6M -51.69% | 154.3M -53.11% | 329.2M +558.71% | |
Short-Term Investments | 190.2M -59.89% | 474.3M -15.08% | 558.5M +37.53% | 406.1M +11.77% | |
Cash and Cash Equivalents and Short-Term Investments | 256.0M -53.35% | 548.9M -23.00% | 712.9M -3.05% | 735.3M +77.89% | |
Total Current Assets | 266.5M -52.91% | 565.8M -22.11% | 726.4M -3.10% | 749.7M +77.86% | |
Accumulated Depreciation | 37.5M +33.66% | 28.1M +24.05% | 22.6M +30.81% | 17.3M +57.76% | |
Property and Plant and Equipment and Net | 10.8M -50.41% | 21.9M -14.34% | 25.5M -6.62% | 27.3M -9.45% | |
Total Long-Term Assets | 386,000 -94.80% | 7.4M +15.74% | 6.4M +14.98% | 5.6M +112.99% | |
Total Assets | 293.2M -52.84% | 621.8M -21.05% | 787.6M -3.32% | 814.7M +66.85% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 366,000 N/A | N/A N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 69.5M -60.94% | 177.9M +89.69% | 93.8M -32.78% | 139.6M +104.96% | |
Total Long-Term Debt | 9.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.7M +26.51% | 1.4M +80.90% | 759,000 +380.38% | 158,000 -66.53% | |
Total Liabilities | 262.6M -46.15% | 487.7M -14.92% | 573.2M +11.53% | 513.9M +132.84% | |
Retained Earnings | -972.1M +36.89% | -710.1M +22.49% | -579.7M +29.86% | -446.4M +8.86% | |
Total Stockholders Equity | 30.6M -77.15% | 134.2M -37.44% | 214.4M -28.69% | 300.7M +12.41% | |
Total Shares Outstanding | 110.4M +30.02% | 84.9M +3.53% | 82.0M +3.37% | 79.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -184.0M -0.07% | -184.2M +805.91% | -20.3M -106.81% | 298.6M +279.06% | |
Capital Expenditures | 41,000 -98.28% | 2.4M -42.17% | 4.1M +26.79% | 3.2M -35.47% | |
Cash from Investing Activities | 196.6M +92.90% | 101.9M +164.09% | -159.0M +220.19% | -49.7M -52.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 20.2M +692.75% | 2.5M -43.51% | 4.5M -85.10% | 30.3M -86.95% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 100.00% N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -156.33% +51.55% | -103.16% +471.79% | -18.04% -98.05% | |
Return on Assets | N/A N/A | -18.50% +11.19% | -16.64% +198.39% | -5.58% -86.66% | |
Return on Equity | N/A N/A | -74.81% +44.55% | -51.75% +304.77% | -12.79% -84.46% | |
Revenue Growth | N/A N/A | -27.36% -22.89% | -35.48% -104.02% | 881.54% +154,701.63% | |
Current Ratio | N/A N/A | 3.18 -58.94% | 7.74 +44.15% | 5.37 -13.22% | |
Cash Ratio | N/A N/A | 0.42 -74.53% | 1.65 -30.25% | 2.36 +221.38% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow